193 related articles for article (PubMed ID: 28680535)
1. Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.
Shen T; Shang C; Zhou H; Luo Y; Barzegar M; Odaka Y; Wu Y; Huang S
Genes Cancer; 2017 Mar; 8(3-4):505-516. PubMed ID: 28680535
[TBL] [Abstract][Full Text] [Related]
2. Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation.
Shen T; Zhou H; Shang C; Luo Y; Wu Y; Huang S
Genes Cancer; 2018 Jan; 9(1-2):39-52. PubMed ID: 29725502
[TBL] [Abstract][Full Text] [Related]
3. The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
Luo Y; Zhou H; Liu L; Shen T; Chen W; Xu B; Han X; Zhang F; Scott RS; Alexander JS; Alam A; Huang S
Oncogene; 2011 May; 30(18):2098-107. PubMed ID: 21217783
[TBL] [Abstract][Full Text] [Related]
4. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
5. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
Huang Z; Huang S
Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
[TBL] [Abstract][Full Text] [Related]
6. The antitumor activity of the fungicide ciclopirox.
Zhou H; Shen T; Luo Y; Liu L; Chen W; Xu B; Han X; Pang J; Rivera CA; Huang S
Int J Cancer; 2010 Nov; 127(10):2467-77. PubMed ID: 20225320
[TBL] [Abstract][Full Text] [Related]
7. Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines.
Wu J; Liu H; Zhang G; Gu L; Zhang Y; Gao J; Wei Y; Ma Z
PLoS One; 2016; 11(8):e0161509. PubMed ID: 27551974
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
[TBL] [Abstract][Full Text] [Related]
9. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome.
Dihazi GH; Bibi A; Jahn O; Nolte J; Mueller GA; Engel W; Dihazi H
World J Stem Cells; 2013 Jan; 5(1):9-25. PubMed ID: 23362436
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
11. Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK/p38 MAPK and NF-κB signaling.
Su Z; Han S; Jin Q; Zhou N; Lu J; Shangguan F; Yu S; Liu Y; Wang L; Lu J; Li Q; Cai L; Wang C; Tian X; Chen L; Zheng W; Lu B
Cell Death Dis; 2021 Mar; 12(3):251. PubMed ID: 33674562
[TBL] [Abstract][Full Text] [Related]
12. Ciclopirox drives growth arrest and autophagic cell death through STAT3 in gastric cancer cells.
Chen L; Chen D; Li J; He L; Chen T; Song D; Shan S; Wang J; Lu X; Lu B
Cell Death Dis; 2022 Nov; 13(11):1007. PubMed ID: 36443287
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A-CDK1 suppresses the expression of the CDK1 activator CDC25A to safeguard timely mitotic entry.
Ng LY; Ma HT; Poon RYC
J Biol Chem; 2023 Mar; 299(3):102957. PubMed ID: 36717077
[TBL] [Abstract][Full Text] [Related]
14. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.
Saha P; Eichbaum Q; Silberman ED; Mayer BJ; Dutta A
Mol Cell Biol; 1997 Aug; 17(8):4338-45. PubMed ID: 9234691
[TBL] [Abstract][Full Text] [Related]
15. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.
Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV
Oncotarget; 2018 Feb; 9(12):10360-10374. PubMed ID: 29535812
[TBL] [Abstract][Full Text] [Related]
16. Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.
Eberhard Y; McDermott SP; Wang X; Gronda M; Venugopal A; Wood TE; Hurren R; Datti A; Batey RA; Wrana J; Antholine WE; Dick JE; Schimmer AD
Blood; 2009 Oct; 114(14):3064-73. PubMed ID: 19589922
[TBL] [Abstract][Full Text] [Related]
17. CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer.
Zhou J; Zhang L; Wang M; Zhou L; Feng X; Yu L; Lan J; Gao W; Zhang C; Bu Y; Huang C; Zhang H; Lei Y
Theranostics; 2019; 9(19):5577-5594. PubMed ID: 31534504
[No Abstract] [Full Text] [Related]
18. Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma.
Wan X; Xiang J; Fan H; Jiang Y; Lu Y; Zhang C; Zhang Y; Chen Q; Lei Y
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678610
[TBL] [Abstract][Full Text] [Related]
19. ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy.
Fan H; He Y; Xiang J; Zhou J; Wan X; You J; Du K; Li Y; Cui L; Wang Y; Zhang C; Bu Y; Lei Y
Redox Biol; 2022 Jul; 53():102339. PubMed ID: 35636017
[TBL] [Abstract][Full Text] [Related]
20. Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer.
Qi J; Zhou N; Li L; Mo S; Zhou Y; Deng Y; Chen T; Shan C; Chen Q; Lu B
Cell Death Dis; 2020 Jul; 11(7):582. PubMed ID: 32719342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]